J. Adachi, Y. Inaba and C. Maki (2017). Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin. Internal medicine (Tokyo, Japan), 56(2), 187-190. https://doi.org/10.2169/internalmedicine.56.7501

PubMed 28090050

[Abstract]
Diabetic ketoacidosis is characterized by hyperglycemia, anion-gap acidosis, and increased plasma ketones. After the resolution of hyperglycemia, persistent diuresis is rare. We herein report the case of a 27-year-old Asian woman with type 2 diabetes who was treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor (canagliflozin) who developed euglycemic diabetic ketoacidosis and persistent diuresis in the absence of hyperglycemia. Physicians should consider euglycemic diabetic ketoacidosis in the differential diagnosis of patients treated with SGLT2 inhibitors.